Therapeutics for Rare and Neglected Diseases program
E93886
The Therapeutics for Rare and Neglected Diseases program is a U.S. government initiative that accelerates the discovery and development of new treatments for rare and underserved diseases that lack adequate commercial investment.
Statements (34)
| Predicate | Object |
|---|---|
| instanceOf |
United States government program
ⓘ
drug development program ⓘ |
| aim |
accelerate development of new therapeutics
ⓘ
accelerate discovery of new therapeutics ⓘ address diseases lacking adequate commercial investment ⓘ de-risk therapeutic candidates for rare and neglected diseases ⓘ |
| collaboratesWith |
academic researchers
ⓘ
non-profit organizations ⓘ small biotechnology companies ⓘ |
| country |
United States of America
ⓘ
surface form:
United States
|
| field |
drug discovery
ⓘ
neglected diseases ⓘ rare diseases ⓘ translational research ⓘ |
| focusesOn |
neglected tropical diseases
ⓘ
rare diseases ⓘ underserved diseases ⓘ |
| fundingSource | United States federal government NERFINISHED ⓘ |
| goal |
enable new treatments to reach patients with neglected diseases
ⓘ
enable new treatments to reach patients with rare diseases ⓘ |
| hasAbbreviation | TRND ⓘ |
| locatedIn | Bethesda, Maryland NERFINISHED ⓘ |
| operatedBy |
National Center for Advancing Translational Sciences
ⓘ
National Institutes of Health ⓘ |
| parentOrganization | National Institutes of Health ⓘ |
| partOf | National Center for Advancing Translational Sciences ⓘ |
| previouslyPartOf | National Human Genome Research Institute ⓘ |
| regulatoryFocus | facilitating Investigational New Drug applications ⓘ |
| supportsStage |
early clinical development
ⓘ
preclinical development ⓘ |
| typeOfSupport |
in-kind drug development expertise
ⓘ
laboratory resources ⓘ project management for therapeutic development ⓘ |
| usesModel | public–private partnership ⓘ |
Referenced by (1)
Full triples — surface form annotated when it differs from this entity's canonical label.
National Center for Advancing Translational Sciences
→
operates
→
Therapeutics for Rare and Neglected Diseases program
ⓘ